The U.S. Food and Drug Administration has issued a new warning about a popular medication used for weight loss.
The FDA says it has received reports of people overdosing on compounded semaglutide, giving themselves as much as 20 times more than the intended dose of the medication.
The incidents, some of which required hospitalization, involve semaglutide that is drawn from a vial and taken by injection, according to the FDA.
The agency said the dosing errors are a result of both patients measuring and self-administering incorrect doses of the medication, as well as health care providers “miscalculating” doses of the medication.
“Many of the patients who received vials of compounded semaglutide lacked experience with self-injections,…
